Document is current
Any future updates will be listed below
-
Authors
Altman, Katherine
Zhou, Chuan
Hernandez-Trujillo, Vivian
Scalchunes, Christopher
Rawlings, David J.
de la Morena, M. Teresa
- License Information
-
More Information
Article History
Received: 10 October 2021
Accepted: 26 January 2022
First Online: 14 March 2022
Declarations
:
: The Immune Deficiency Foundation sponsored the mail surveys and submitted both survey protocols (IDF 2017 Patient Survey and the IDF 2018 Immunoglobulin Treatment Experiences and Preferences Surveys) for review by independent IRBs and each received exemption of oversight based on the Department of Health and Human Services regulations found at 45 CFR 46.101 (b)(2).
: Not applicable.
: Not applicable.
: VHT is on the advisory board for CSL-Behring, Regeneron, and Takeda. VHT is a speaker and consultant for Takeda. CS is employed by the Immune Deficiency Foundation. DJR is recipient of research funding support from CSL-Behring. All other authors declare no competing interests.
